US drugmaker Pfizer Inc, which has developed a 95% effective vaccine against coronavirus, is now seeking the emergency use tag from the US government for its dosage.
The head of the US effort to produce a coronavirus vaccine has said, the first immunizations could happen on December 12.
A Food and Drug Administration advisory committee is set to meet on December 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing Covid-19 vaccine.
US drugmaker Pfizer Inc, which has developed a 95% effective vaccine against coronavirus, is now seeking the emergency use tag from the US government for its dosage. Pfizer has said the emergency use tag could start the process early and the coronavirus vaccine doses could be available as early as next month.
Dr. Moncef Slaoui, head of Operation Warp Speed, the coronavirus vaccine program, said, “Our plan is to be able to ship vaccines to the immunization sites within 24 hours from the approval, so I expect maybe on day two after approval on the 11th or the 12th of December,” he said
Slaoui told CNN he expects vaccinations would begin on the second day after approval, December 12.
On Wednesday, Pfizer said the final results of its ongoing coronavirus vaccine trials have suggested that the Pfizer coronavirus vaccine shots are 95% effective, a month after the first dose was administered.
PM Modi to address UN General Assembly on his visit to US
The Paralympics Games officially begins at the National Stadium in Tokyo
UAE temporarily suspends the visa-on-arrival facility for passengers arriving from India